Monika S.
- Country
- Poland
- Department
- Department of Hematology and Transplantology
Research Overview
- Efficacy and Safety of Birtamimab with Standard Care versus Placebo in Mayo Stage IV Light Chain Amyloidosis: A Phase 3 Randomized, Double-Blind Study
- Phase 3 Multicenter Randomized Open-Label Study of ABBV-383 Monotherapy Versus Standard Therapy in Relapsed/Refractory Multiple Myeloma Patients
- Evaluation of CAEL-101 and Plasma Cell Dyscrasia Treatment Efficacy and Safety in Treatment-Naïve Mayo Stage IIIb AL Amyloidosis Patients
Data & Insights
Has run more than one trial at 79 of 217 partner sites.
Specializations
Multiple Myeloma Research
The investigator specializes in treating multiple myeloma, with particular focus on managing both newly diagnosed cases and relapsed/refractory multiple myeloma. Their work encompasses novel therapeutic combinations and treatment approaches for patients at different disease stages.
- Monotherapy and combination treatments
- Post-transplant therapy
- Novel agent evaluation
Research includes assessment of innovative treatment regimens involving targeted therapies and immunomodulatory agents.
Lymphoma Studies
Focuses on advanced treatments for various lymphoma types, including Classical Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma, and Diffuse Large B-Cell Lymphoma.
- Immunotherapy applications
- Treatment of refractory disease
- Novel therapeutic combinations
Investigates innovative approaches in treating resistant and relapsed forms of lymphoma.
Leukemia and Rare Blood Disorders
Conducts research in Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and rare conditions like Light Chain Amyloidosis and Myelodysplastic Syndrome.
- Targeted molecular therapies
- Novel treatment protocols
- Rare disease management
Explores innovative therapeutic strategies for various hematologic malignancies and disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.